Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient
7.7.2026 05:00:00 EEST | Business Wire | Press release
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/
Growing Interest in Postbiotics and Mental Well-Being
Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing awareness of the connection between the gut and the brain, commonly referred to as the gut–brain axis. As a result, the global functional ingredient market is evolving beyond conventional probiotics to include postbiotics—non-viable microorganisms and/or their components that offer physiological benefits. Postbiotics are gaining attention due to their stability, safety, and ease of formulation, particularly in product formats that are challenging for live microorganisms. These advantages make them an attractive option for manufacturers seeking reliable, science-based ingredients.
Morinaga Milk has been at the forefront of postbiotic research and development. In 2018, the company achieved self-affirmed GRAS status for LAC-Shield™ (L. paracasei MCC1849), its first postbiotic ingredient. Building on this experience, LAC-Living+™ represents the company’s second postbiotic innovation, developed to address emerging consumer needs in the area of mood and mental well-being.
LAC-Living+™: Clinical Evidence Supporting Everyday Well-Being
LAC-Living+™ (L. helveticus MCC1848) is a heat-treated postbiotic ingredient developed to combine scientific credibility with formulation flexibility. Its functionality has been evaluated in human clinical studies, which suggest that supplementation with LAC-Living+ may help support mental well-being and quality of life, particularly in individuals experiencing everyday stress. Reported outcomes have included improvements in indicators related to mood and psychological state, providing a scientific basis for its application in products targeting mental wellness. In Japan, L. helveticus MCC1848 has also been accepted as a functional ingredient under the Foods with Function Claims (FFC) system, with reported functionality to help maintain a positive mood (vitality) in situations involving temporary mental stress. While research into the gut–brain axis continues to evolve, such findings and achievements are contributing to a growing body of evidence supporting the role of microbiome-related ingredients in holistic health approaches that integrate physical and mental well-being.
Formulation Advantages for Broad Applications
In addition to its scientific foundation, LAC-Living+™ offers important technical advantages for product development.
As a postbiotic ingredient, LAC-Living+™ is non-viable, which allows it to maintain stability under conditions that may compromise live microorganisms. This includes exposure to heat processing, moisture, and extended shelf-life environments, making it suitable for a wide variety of applications. These characteristics provide manufacturers with greater flexibility in formulation and product design, supporting its use across categories such as ready-to-drink beverages, powders, bars, gummies, dairy products, and supplements.
Supporting Innovation in the U.S. Market
The attainment of self-affirmed GRAS status represents a key step in enabling broader adoption of LAC-Living+™ in the United States.
“Achieving self-affirmed GRAS status for LAC-Living+™ marks an important milestone for our postbiotic portfolio,” said Masashi Kamiya, General Manager of Functional Food Ingredients Division at Morinaga Milk Industry Co., Ltd. “With increasing interest in mental well-being and convenient health solutions, we believe LAC-Living+™ offers strong potential to support our partners in developing innovative products tailored to evolving consumer needs.”
Morinaga Milk remains committed to advancing its research and ingredient development efforts, with a focus on delivering safe, scientifically supported, and application-friendly solutions to the global market.
About Morinaga Milk Industry Co., Ltd.
Morinaga Milk Industry Co., Ltd. is one of Japan’s leading dairy companies, with more than 100 years of experience in harnessing the nutritional value of dairy and functional ingredients.
The company is recognized globally for its expertise in probiotics, postbiotics, and microbiome-related research, supported by decades of scientific investigation into the safety, functionality, and mechanisms of action of beneficial microorganisms. Since the 1960s, Morinaga Milk has been advancing research into bifidobacteria and their role in human health, contributing to the development of high-quality, science-based solutions for a wide range of applications.
For more information about Morinaga probiotics and postbiotics, please visit: https://morinagamilk-ingredients.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20260706806943/en/
Contacts
Morinaga Milk Industry Co., Ltd.
Investor& Public Relations Department: Kazuaki Kajikawa
Functional Food Ingredients Division: Saki Yamashita
E-mail:interntl-pr@morinagamilk.co.jp
Morinaga Milk website: https://www.morinagamilk.co.jp/english/ -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.morinagami
lk.co.jp%2Fenglish%2F&esheet=54565568&newsitemid=20260706806943&lan=en-US&anchor
=https%3A%2F%2Fwww.morinagamilk.co.jp%2Fenglish%2F&index=2&md5=99286906205e029ef
a334bb310456c04
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samos Energy Acquisition Corporation Announces Pricing of Initial Public Offering10.7.2026 16:32:00 EEST | Press release
Samos Energy Acquisition Corporation (the “Company”) announced today the pricing of its initial public offering (“IPO”) of 20,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “SAMO.U” beginning on July 10, 2026. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one of the Company’s Class A ordinary shares at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “SAMO” and “SAMO.WS,” respectively. Cantor Fitzgerald & Co. is acting as the sole book running manager for the proposed offering. The Company has granted the underwriter a 45-day option to purchase up to an additional 3,000,000 units at the IPO price. The public offering is being made
Onera hPSG ® Wins Prestigious Red Dot Product Design Award10.7.2026 16:00:00 EEST | Press release
Onera Health, a leader in transforming sleep medicine, announces that its innovative product, Onera hPSG®, has been honoured with the prestigious Red Dot Product Design Award for 2026. This international recognition celebrates exceptional design quality and underscores Onera Health's commitment to excellence, creativity, and patient-centric innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260710266668/en/ Onera Health's patch-based home polysomnography solution, Onera hPSG®, wins Prestigious Red Dot Product Design Award 2026. The Red Dot Award, one of the most sought-after seals of quality for good design, attracted thousands of entries from around the globe. Onera hPSG® stood out for outstanding functionality, striking aesthetics, and thoughtful user experience. The expert jury praised the product for translating complex sleep diagnostics into a wearable, easy-to-use system that enables low-threshold application.
teamLab Biovortex Kyoto Welcomes Over 1 Million Visitors within 9 Months of Opening10.7.2026 10:00:00 EEST | Press release
teamLab Biovortex Kyoto has welcomed over 1 million visitors as of July 6, 2026, 9 months after its grand opening. (*1) These visitors arrived from more than 150 countries and regions. International visitors account for approximately 42% of the total. Many of these international visitors travel from distant countries and regions, including the United States, Australia, Canada, the United Kingdom, and Germany. Approximately 30% of these international visitors purchase their tickets at least 30 days in advance. teamLab Biovortex Kyoto is teamLab's largest museum in Japan, with an average visitor stay of over two and a half hours. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260709913938/en/ teamLab Biovortex Kyoto Welcomes Over 1 Million Visitors within 9 Months of Opening *1 According to ticket purchase data from the official teamLab Biovortex Kyoto website (survey period: October 7, 2025 – July 6, 2026) Visitors Comment (M
Robbyant Launches LingBot-VA 2.0 Built Natively for Embodied AI and Physical World Control10.7.2026 09:48:00 EEST | Press release
Robbyant, an embodied AI company within Ant Group, today announced the release of LingBot-VA 2.0, the industry’s first embodied-native video-action world model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260709654440/en/ A robot powered by LingBot-VA 2.0 engages in a real-time tabletop air hockey match with a human This release marks a key transition in robotics foundation models, shifting from repurposing digital world models to designing them natively for the physical world. Instead of relying on fine-tuned digital content generation models, LingBot-VA 2.0 is built from scratch to meet the original demands of dynamic modeling, causal prediction, and real-time execution in physical environments. Integrating world models with embodied AI has been one of the major focuses of the AI industry. However, most mainstream approaches rely on video generation models designed for digital content, which are then fine-tuned for robo
SureWerx Appoints Erik Pertot as VP/GM SureWerx EMEA10.7.2026 09:00:00 EEST | Press release
SureWerx, a leading global manufacturer of personal protective equipment, safety products, tools and equipment solutions, today announced the appointment of Erik Pertot as VP/GM SureWerx EMEA. Pertot will report directly to CEO Scott Dowell and will lead growth, manufacturing and M&A activities in Europe across the company’s global portfolio. Erik joins SureWerx with more than 20 years of international leadership experience across engineering, quality, marketing, sales, international supply chain, product management, and general management. He brings deep expertise in the personal protective equipment industry, with a track record of leading complex, compliance-critical programs, managing business transitions, and driving growth across multinational environments. Most recently, Pertot served as Global General Manager for Footwear and Fall Protection at Protective Industrial Products (PIP), where he also held senior portfolio management leadership roles. Prior to that, he held a series
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom